AN ACT CONCERNING THE OVERRIDE OF STEP THERAPY FOR CERTAIN MENTAL HEALTH CONDITIONS AND ESTABLISHING A TASK...
Do you support it?
Want to know if it passes?
We'll email you when HB 6831 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HB 6831.
You're tracking HB 6831
We'll email you the moment it moves.
HB 6831 — AN ACT CONCERNING THE OVERRIDE OF STEP THERAPY FOR CERTAIN MENTAL HEALTH CONDITIONS AND ESTABLISHING A TASK FORCE TO STUDY DATA COLLECTION EFFORTS REGARDING STEP THERAPY.
Last action — SENATE CALENDAR NUMBER 460
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2023 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Bill Text
What changed in the latest version
147 added · 39 removed147 line(s) added, 39 removed.
House of Representatives General Assembly RaisedFile Bill No.
6831334 January Session, 2023 LCOSubstitute House Bill No.
31516831 ReferredHouse toof Representatives, March 30, 2023 The Committee on INSURANCEInsurance ANDand REALReal ESTATEEstate Introducedreported by:through REP.
(INS)WOOD ANof ACTthe CONCERNING29th THEDist., OVERRIDEChairperson OFof STEPthe THERAPYCommittee FORon CERTAINthe MENTALpart HEALTHof CONDITIONS.the House, that the substitute bill ought to pass.
AN ACT CONCERNING THE OVERRIDE OF STEP THERAPY FOR CERTAIN MENTAL HEALTH CONDITIONS AND ESTABLISHING A TASK FORCE TO STUDY DATA COLLECTION EFFORTS REGARDING STEP THERAPY.
Such disclosure shall be made to health care providers, in writing, not less than once each calendar year and such health care provider shall display in a conspicuoussHB6831 and/ prominentFile location,No. including the provider's Internet web site and on a bulletin board in the provider's office, information regarding the override process.
Any334 such1 overridesHB6831 processFile shall be LCO No.
3151334 1conspicuous of 5 Raised Bill No.6831 convenient to use by health care providers and anprominent overridelocation, requestincluding shall be expeditiously granted when an insured's treating health care provider demonstrates that the drugprovider's regimenInternet requiredweb undersite stepand therapy (A)has beenineffective inthepast for treatment oftheinsured's medical condition, (B) is expected to be ineffective based on thea knownbulletin relevantboard physicalin or mental characteristics of the insuredprovider's andoffice, theinformation knownregarding characteristics of the drugoverride regimen,process. (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.
Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured's treating health care provider demonstrates that the drug regimen required under step therapy (A)has beenineffective inthepast for treatment oftheinsured's medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.
Any such override process shall be convenient to use by health care providers and an override request shall besHB6831 expeditiously/ grantedFile when an insured's treating health care provider demonstrates that the drug regimen required under step therapy (A)has beenineffective inthepast for treatment oftheinsured's LCO No.
3151334 2 ofsHB6831 5File RaisedNo. Bill No.6831 medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.
334 be expeditiously granted when an insured's treating health care provider demonstrates that the drug regimen required under step therapy (A)has beenineffective inthepast for treatment oftheinsured's medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.
(1) One appointed by the speaker of the House of Representatives, who isshall be a health care provider with expertise in mental health;
(2) One appointed by the president pro tempore of the Senate, who isshall be a health care provider with expertise in mental health;
(3) One appointed by the minority leader of the House of Representatives, who isshall be a healthpharmacist carelicensed providerunder withchapter expertise400j inof mentalthe health;general statutes;
(4) One appointed by the minority leader of the Senate, who isshall be a healthrepresentative careof providerthe withpharmaceutical expertisemanufacturing inindustry; mental health;
(5) The chairpersons and ranking members of the joint standing committees of the General Assembly having cognizance of matters relatingsHB6831 to/ publicFile healthNo. and insurance, or their designees;
(6)334 The3 executivesHB6831 directorFile of the Office of Health Strategy, or the LCO No.
3151334 3relating ofto 5public Raisedhealth Billand No.6831insurance, executiveor director'stheir designee;designees;
(6) The executive director of the Office of Health Strategy, or the executive director's designee;
(c) TheAll administrativeinitial staffappointments ofto the jointtask standingforce committeeshall ofbe themade Generalnot Assemblylater havingthanthirty cognizancedaysafter oftheeffective mattersdate relatingofthis tosection.Any publicvacancy health shall servebe asfilled administrativeby staff of the taskappointing force.authority.
(d)NotlaterthanFebruary1,2024,thetaskforceshallsubmitareport(d) onThe itsspeaker findingsof andthe recommendationsHouse concerning subsection (a) of thisRepresentatives sectionand tothe thejointpresident standingpro committeesoftheGeneralAssemblytempore havingof cognizancethe ofSenate mattersshall relatingselect tothe insurancechairpersons andof publicthe health,task inforce accordancefrom withamong the provisionsmembers of section 11-4a of the generaltask statutes.force.
Such chairpersons shall schedule the first meeting of the task force, which shall be held not later than sixty days after the effective date of this section.
(e) The administrative staff of the joint standing committee of the sHB6831 / File No.
334 4 sHB6831 File No.
334 General Assembly having cognizance of matters relating to public health shall serve as administrative staff of the task force.
(f) Not later than February 1, 2024, the task force shall submit a report on its findings and recommendations concerning subsection (a) of this sectionto thejoint standing committeesoftheGeneralAssembly having cognizance of matters relating to insurance and public health, in accordance with the provisions of section 11-4a of the general statutes.
LCOThis No.act shall take effect as follows and shall amend the following sections:
3151 4 of 5 Raised Bill No.
6831 This act shall take effect as follows and shall amend the following sections:
3 from passage New section StatementINS ofJoint Purpose:Favorable Subst.
TosHB6831 (1)/ allowFile providersNo. to override step therapy for certain mental health conditions, and (2) establish a task force to study data collection efforts regarding step therapy.
[Proposed334 deletions5 aresHB6831 enclosedFile inNo. brackets.
Proposed334 additionsThe following Fiscal Impact Statement and Bill Analysis are indicatedprepared byfor underline,the exceptbenefit thatof whenthe members of the entireGeneral textAssembly, solely for purposes of ainformation, billsummarization orand resolutionexplanation orand ado sectionnot ofrepresent athe billintent orof resolutionthe isGeneral new,Assembly itor iseither notchamber underlined.]thereof LCOfor No.any purpose.
3151In 5general, fiscal impacts are based upon a variety of 5informational sources, including the analyst’s professional knowledge.
Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.
OFA Fiscal Note State Impact:
None Municipal Impact:
Municipalities Effect FY 24 $ FY 25 $ Various Municipalities Potential See Below See Below Cost Explanation The bill does not result in a fiscal impact to the state employee and retiree health plan or municipalities that participate in the Partnership Plan as step therapy is not required in the treatment of mental health conditionsoutlinedinthebill.Thesteptherapyoverrideprovisionsmay increase costs to certain fully insured municipal plans which currently require step therapy for treatment of schizophrenia, major depressive disorder, and bipolar disorder.
Section 3 establishes a task force to study data collection efforts regarding step therapy resulting in no fiscal impact to the state because the task force has the expertise to meet the requirements of the bill.
Show all 85 changed lines (45 more)
The Out Years The annualized ongoing fiscal impact identified above would continue into the future subject to inflation.
sHB6831 / File No.
334 6 sHB6831 File No.
334 OLR Bill Analysis sHB 6831 AN ACT CONCERNING THE OVERRIDE OF STEP THERAPY FOR CERTAIN MENTAL HEALTH CONDITIONS AND ESTABLISHING A TASK FORCE TO STUDY DATA COLLECTION EFFORTS REGARDING STEP THERAPY.
SUMMARY By law, health carriers (e.g., insurers and HMOs) that use step therapy (i.e., fail first protocols) for covering prescription drugs must have a process that they disclose to health care providers for overriding the step therapy process.
This bill requires health carriers to disclose the steptherapyoverrideprocesstoproviders inwritingatleastonceayear.
It also requires providers to display information about the override process in a conspicuous and prominent location, including on their website and an office bulletin board.
Additionally, from October 1, 2023, to October 1, 2026, the bill requires health carriers to grant a step therapy override request for drugs prescribed to treat schizophrenia, major depressive disorder, or bipolar disorder within 24 hours after a request is made.
Lastly, the bill establishes a 19-member task force to study step therapy data collection, including step therapy edits, rejections, and appeals for behavioral health drugs, and the best ways to collect data.
It requiresthetask force to report itsfindingsandrecommendationsto the Insurance and Real Estate and Public Health committees by February 1, 2024.
The task force terminateswhenit submitsitsreport or onFebruary 1, 2024, whichever is earlier.
EFFECTIVE DATE:
October 1, 2023, except the task force provisions are effective upon passage.
sHB6831 / File No.
334 7 sHB6831 File No.
334 STEP THERAPY TASK FORCE Under the bill, the task force includes the following members:
1.
two health care providers with mental health expertise, one each appointed by the House speaker and the Senate president pro tempore;
2.
one licensed pharmacist, appointed by the House minority leader;
3.
one pharmaceutical manufacturing industry representative, appointed by the Senate minority leader;
4.
the chairpersons and ranking members of the Insurance and Real Estate and Public Health committees, or their designees;
5.
the Office of Health Strategy executive director, or her designee;
6.
the insurance and consumer protection commissioners, or their designees;
7.
one insurance industry representative, appointed by the Insurance and Real Estate Committee’s House chairperson;
8.
one pharmaceutical industry representative, appointed by the Insurance and Real Estate Committee’s House ranking member;
9.
one mental health care provider, appointed by the Insurance and Real Estate Committee’s House chairperson;
and 10.
one mental health advocacy group representative who is an impacted individual, appointed by the Public Health Committee’s House ranking member.
The bill requires the appointing authorities to make their appointments within 30 days after the bill’s passage and fill any vacancies.
The bill also requires the House speaker and Senate president pro sHB6831 / File No.
334 8 sHB6831 File No.
334 tempore to select the task force’s chairpersons from among its members.
The chairpersons must schedule the first meeting, which must be held within 60 days after the bill’s passage.
The Public Health Committee’s administrative staff serve as the task force’s staff.
BACKGROUND Related Bill SB6, reported favorably by theInsurance and RealEstate Committee, prohibits health carriers from using step therapy for drugs prescribed to treat a behavioral health condition or a disabling, chronic, or life- threatening condition or disease.
COMMITTEE ACTION Insurance and Real Estate Committee Joint Favorable Substitute Yea 11 Nay 1 (03/14/2023) sHB6831 / File No.
334 9
Show all 85 changed rows (45 more)
View plain text versions (3)
- File No. 334 View text pdf
- Raised Bill View text Current pdf
- Substitute INS Joint Favorable Substitute pdf
Action History
-
SENATE CALENDAR NUMBER 460
-
FAV. RPT., TAB. FOR CAL., SEN.
-
HOUSE PASSED
-
FILE NO. 334
-
HOUSE CALENDAR NUMBER 233
-
FAV. RPT., TABLED FOR HOUSE CALENDAR
-
RPTD. OUT OF LCO
-
REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 03/29/23
-
FILED WITH LCO
-
Joint Favorable Substitute
-
PUBLIC HEARING 0309
-
REF. TO JOINT COMM. ON Insurance and Real Estate
Sponsors
- Christie M. Carpino · Primary
- Michelle L. Cook · Primary
- Nicole Klarides-Ditria · Primary
- Tom Delnicki · Primary
- Robin E. Comey · Primary
- Saud Anwar · Primary
Sponsorship breakdown
Export CSV (upgrade) →6 sponsors · 0 co-sponsors · 181 not signed on
Sponsors (6)
- Christie M. Carpino Republican
- Cook, Michelle L.
- Nicole Klarides-Ditria Republican
- Tom Delnicki Republican
- Robin E. Comey Democratic
- Saud Anwar Democratic
Co-sponsors (0)
None.
Not signed on (181)
181 members have not signed on to this bill.
Show all 181 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors HB 6831?
- HB 6831 is sponsored by Christie M. Carpino (Republican), Cook, Michelle L., Nicole Klarides-Ditria (Republican), Tom Delnicki (Republican), Robin E. Comey (Democratic), and Saud Anwar (Democratic).
- What is the current status of HB 6831?
- This bill died with 2023 Regular Session. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HB 6831?
- Track HB 6831 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 6831
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 6831
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →